Risperidone Starting Dose for Autism
For children and adolescents with autism, start risperidone at 0.25 mg per day for those weighing less than 20 kg, or 0.5 mg per day for those weighing 20 kg or more 1.
Weight-Based Dosing Algorithm
The FDA-approved dosing protocol is straightforward and weight-dependent 1:
Initial Dosing (Day 1-4)
- < 20 kg: Start at 0.25 mg once daily
- ≥ 20 kg: Start at 0.5 mg once daily
First Dose Increase (After minimum 4 days)
- < 20 kg: Increase to 0.5 mg per day (target dose)
- ≥ 20 kg: Increase to 1 mg per day (target dose)
Maintain this target dose for a minimum of 14 days before considering further increases 1.
Further Titration (If needed after 14 days at target)
If insufficient clinical response after 14 days at target dose, increase at intervals of 2 weeks or greater:
- < 20 kg: Increase by 0.25 mg increments
- ≥ 20 kg: Increase by 0.5 mg increments
The effective dose range is 0.5 to 3 mg per day 1.
Timing and Administration
The total daily dose can be given once daily (morning or evening) or split into twice-daily dosing 1. If persistent somnolence occurs, consider administering the dose at bedtime or splitting into twice-daily administration 1. This flexibility in timing helps manage one of the most common side effects.
Clinical Context and Evidence Base
Risperidone is FDA-approved specifically for treating irritability associated with autism, which encompasses aggression toward others, deliberate self-injury, temper tantrums, and quickly changing moods 1. The AACAP guidelines support pharmacotherapy when there is a specific target symptom, particularly severe behavioral disturbances 2.
The evidence supporting these doses comes from pivotal trials showing that:
- Mean effective doses were approximately 1.4-1.9 mg/day 1
- Lower doses (0.125-0.175 mg/day) did NOT demonstrate efficacy in controlled trials 1, 3
- The recommended starting doses lead to therapeutic levels when properly titrated
Critical Pitfalls to Avoid
Do not start with subtherapeutic doses below 0.25 mg/day - a fixed-dose study demonstrated that doses of 0.125-0.175 mg/day were ineffective and no better than placebo 1, 3. This is a common error that delays therapeutic benefit.
Do not rush titration - the FDA label specifically requires maintaining the initial target dose (0.5 mg for <20 kg, 1 mg for ≥20 kg) for a minimum of 14 days before increasing 1. Premature dose escalation increases side effect risk without allowing adequate time to assess response.
Do not use risperidone for core autism symptoms - it is indicated for irritability and associated behavioral problems, not for improving social communication deficits 2.
Monitoring Considerations
Common side effects include sedation, increased appetite, and weight gain 1. Weight gain averaged 2.7 kg over 8 weeks in clinical trials 4. Monitor weight, appetite, and sedation closely, especially during titration. Combining medication with parent training is more effective than medication alone 2.
The physician should periodically re-evaluate the long-term risks and benefits, as most controlled trial data extend only to 8 weeks, though open-label extensions suggest maintained benefit at 6 months 1.